Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMTX Immatics N.V.

盘后交易 05-20 19:34:16 EDT

10.94

-0.02

-0.18%

盘后10.94

+0.000.00%

16:00 EDT

最高11.05	最低10.64	成交量53.47万
今开10.96	昨收10.96	日振幅3.79%
总市值11.27亿	流通市值7.22亿	总股本1.03亿
成交额579.03万	换手率0.81%	流通股本6,595万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMTX","market":"US","secType":"STK","nameCN":"Immatics N.V.","latestPrice":10.94,"timestamp":1716235200000,"preClose":10.96,"halted":0,"volume":534718,"hourTrading":{"tag":"盘后","latestPrice":10.94,"preClose":10.94,"latestTime":"16:00 EDT","volume":9194,"amount":100582.36,"timestamp":1716235204244},"delay":0,"floatShares":65952072,"shares":102985072,"eps":-0.995687,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.02,"latestTime":"05-20 19:34:16 EDT","open":10.96,"high":11.05,"low":10.635,"amount":5790263.911058,"amplitude":0.037865,"askPrice":13.89,"askSize":100,"bidPrice":9.3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.995687,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1716249600000},"adr":0,"adjPreClose":10.96,"postHourTrading":{"tag":"盘后","latestPrice":10.94,"preClose":10.94,"latestTime":"16:00 EDT","volume":9194,"amount":100582.36,"timestamp":1716235204244},"volumeRatio":0.602626},"requestUrl":"/m/hq/s/IMTX","defaultTab":"news","newsList":[{"id":"2435968809","title":"近90%患者肿瘤缩小！Immatics(IMTX.US)创新细胞疗法2/3期试验即将启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2435968809","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2435968809?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:28","pubTimestamp":1715758122,"startTime":"0","endTime":"0","summary":"IMA203是由Immatics专有ACTengine平台所开发的TCR-T细胞，靶向由HLA-A*02呈递的黑素瘤抗原PRAME。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20240515/20240515152915_29906.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240515/20240515152915_29906.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1121493.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435519032","title":"Immatics N.V.盘中异动 早盘快速拉升7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519032","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435519032?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:32","pubTimestamp":1715693574,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时32分，Immatics N.V.股票出现异动，股价快速拉升7.27%。截至发稿，该股报11.80美元/股，成交量2.1404万股，换手率0.02%，振幅2.55%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为0.14%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142132548b07d7bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142132548b07d7bb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432801126","title":"Immatics N.V.盘中异动 下午盘大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432801126","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432801126?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:27","pubTimestamp":1714588064,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时27分，Immatics N.V.股票出现异动，股价急速上涨5.04%。截至发稿，该股报10.43美元/股，成交量24.0438万股，换手率0.23%，振幅4.73%。Immatics N.V.股票所在的生物技术行业中，整体涨幅为1.45%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502022744861ea914&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502022744861ea914&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420747502","title":"Immatics N.V.盘中异动 股价大涨6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420747502","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420747502?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:31","pubTimestamp":1710941469,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时31分，Immatics N.V.股票出现异动，股价急速上涨6.95%。截至发稿，该股报12.47美元/股，成交量3061股，换手率0.00%，振幅1.29%。Immatics N.V.股票所在的生物技术行业中，整体跌幅为0.41%。Immatics N.V.公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。该公司通过与第三方制药和生物技术公司的战略合作协议获得收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213109861dfc06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213109861dfc06&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413096284","title":"Immatics N V盘中异动 快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413096284","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413096284?lang=zh_cn&edition=full","pubTime":"2024-02-22 04:58","pubTimestamp":1708549133,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日04时58分，Immatics N V股票出现异动，股价快速上涨5.01%。Immatics N V股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Ventyx Biosciences Inc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Revelation Biosciences Inc、Ventyx Biosciences Inc、Zyversa Therapeutics Inc较为活跃，换手率分别为313.64%、147.35%、84.03%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Ventyx Biosciences Inc，振幅分别为162.34%、129.75%、117.73%。Immatics N V公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222045853861d7261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222045853861d7261&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411368241","title":"Immatics N V盘中异动 股价大跌5.11%报10.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411368241","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411368241?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:31","pubTimestamp":1707834662,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时31分，Immatics N V股票出现异动，股价急速下挫5.11%。截至发稿，该股报10.90美元/股，成交量1698股，换手率0.00%，振幅0.77%。Immatics N V股票所在的生物技术行业中，整体跌幅为0.66%。Immatics N V公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322310287e6fde3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322310287e6fde3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2407036409","title":"Immatics N V盘中异动 股价大跌5.07%报11.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407036409","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407036409?lang=zh_cn&edition=full","pubTime":"2024-01-31 00:17","pubTimestamp":1706631460,"startTime":"0","endTime":"0","summary":"北京时间2024年01月31日00时17分，Immatics N V股票出现波动，股价大幅下跌5.07%。Immatics N V股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Neximmune Inc、Pepgen Inc、Psyence Biomedical Ltd涨幅较大，Neximmune Inc、Panbela Therapeutics Inc、Iterum Therapeutics Plc较为活跃，换手率分别为936.44%、231.78%、164.61%，振幅较大的相关个股有Psyence Biomedical Ltd、Neximmune Inc、Pepgen Inc，振幅分别为800.00%、211.72%、61.72%。Immatics N V公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401310017417a3fbbfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401310017417a3fbbfd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404036415","title":"Immatics N V盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404036415","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404036415?lang=zh_cn&edition=full","pubTime":"2024-01-18 01:59","pubTimestamp":1705514369,"startTime":"0","endTime":"0","summary":"北京时间2024年01月18日01时59分，Immatics N V股票出现波动，股价大幅下挫5.00%。Immatics N V股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Revolution Medicines Inc C/Wts  、Artelo Biosciences Inc C/Wts 20/06/2024 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Kintara Therapeutics Inc、Zyversa Therapeutics Inc、Windtree Therapeutics Inc较为活跃，换手率分别为1257.09%、906.67%、80.83%，振幅较大的相关个股有Dermata Therapeutics Inc C/Wts 13/08/2026 、Moolec Science Sa C/Wts 、Revolution Medicines Inc C/Wts  ，振幅分别为170.37%、96.36%、76.26%。Immatics N V公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011801592987e65e89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011801592987e65e89&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2403893038","title":"Immatics N V盘中异动 股价大跌5.02%报11.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2403893038","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2403893038?lang=zh_cn&edition=full","pubTime":"2024-01-16 23:14","pubTimestamp":1705418046,"startTime":"0","endTime":"0","summary":"北京时间2024年01月16日23时14分，Immatics N V股票出现波动，股价大幅跳水5.02%。截至发稿，该股报11.92美元/股，成交量16.1848万股，换手率0.19%，振幅3.27%。Immatics N V股票所在的生物技术行业中，整体跌幅为0.18%。Immatics N V公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011623140779096715&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011623140779096715&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402158924","title":"Immatics N V盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402158924","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402158924?lang=zh_cn&edition=full","pubTime":"2024-01-10 00:12","pubTimestamp":1704816739,"startTime":"0","endTime":"0","summary":"北京时间2024年01月10日00时12分，Immatics N V股票出现异动，股价急速上涨5.07%。Immatics N V股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Neximmune Inc、艾切托、Cingulate Inc涨幅较大，Neximmune Inc、Novabay Pharmaceuticals Inc、Notable Labs Ltd较为活跃，换手率分别为812.95%、218.86%、48.60%，振幅较大的相关个股有Neximmune Inc、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Dermata Therapeutics Inc C/Wts 13/08/2026 ，振幅分别为111.49%、85.00%、44.18%。Immatics N V公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011000121987e645b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011000121987e645b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2401343139","title":"Immatics N V盘中异动 股价大涨5.03%报10.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2401343139","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2401343139?lang=zh_cn&edition=full","pubTime":"2024-01-05 02:45","pubTimestamp":1704393945,"startTime":"0","endTime":"0","summary":"北京时间2024年01月05日02时45分，Immatics N V股票出现异动，股价快速上涨5.03%。截至发稿，该股报10.75美元/股，成交量8.0643万股，换手率0.10%，振幅4.49%。Immatics N V股票所在的生物技术行业中，整体涨幅为1.57%。Immatics N V公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240105024545861c8858&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240105024545861c8858&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2394722634","title":"Immatics N V盘中异动 急速上涨5.05%报10.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2394722634","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2394722634?lang=zh_cn&edition=full","pubTime":"2023-12-27 02:34","pubTimestamp":1703615683,"startTime":"0","endTime":"0","summary":"北京时间2023年12月27日02时34分，Immatics N V股票出现波动，股价急速上涨5.05%。截至发稿，该股报10.40美元/股，成交量25.0842万股，换手率0.30%，振幅5.35%。Immatics N V股票所在的生物技术行业中，整体涨幅为0.39%。Immatics N V公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231227023444861c6dfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231227023444861c6dfd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393822864","title":"Immatics N V盘中异动 大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2393822864","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393822864?lang=zh_cn&edition=full","pubTime":"2023-12-22 04:16","pubTimestamp":1703189791,"startTime":"0","endTime":"0","summary":"北京时间2023年12月22日04时16分，Immatics N V股票出现异动，股价大幅拉升5.13%。Immatics N V股票所在的生物技术行业中，整体涨幅为0.59%。Immatics N V公司简介：Immatics NV 是一家生物技术公司，致力于研究和开发用于治疗癌症患者的 T 细胞重定向免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312220416317a34fc10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312220416317a34fc10&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immatics.com","stockEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.0714},{"period":"3month","weight":-0.0608},{"period":"6month","weight":0.2627},{"period":"1year","weight":0.1322},{"period":"ytd","weight":0.0408}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immatics N.V.是一家荷兰私人有限责任公司，于2020年3月10日成立。该公司是一家专注于开发基于T细胞受体的免疫疗法的生物制药公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.063537},{"month":2,"riseRate":0.75,"avgChangeRate":-0.011615},{"month":3,"riseRate":0.25,"avgChangeRate":-0.076889},{"month":4,"riseRate":0.5,"avgChangeRate":0.010902},{"month":5,"riseRate":0.5,"avgChangeRate":0.084695},{"month":6,"riseRate":1,"avgChangeRate":0.133704},{"month":7,"riseRate":1,"avgChangeRate":0.11938},{"month":8,"riseRate":0.5,"avgChangeRate":0.014434},{"month":9,"riseRate":0.25,"avgChangeRate":-0.032053},{"month":10,"riseRate":0.5,"avgChangeRate":-0.032187},{"month":11,"riseRate":0.25,"avgChangeRate":-0.034864},{"month":12,"riseRate":0.75,"avgChangeRate":0.065405}],"exchange":"NASDAQ","name":"Immatics N.V.","nameEN":"Immatics N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immatics N.V.,IMTX,Immatics N.V.股票,Immatics N.V.股票老虎,Immatics N.V.股票老虎国际,Immatics N.V.行情,Immatics N.V.股票行情,Immatics N.V.股价,Immatics N.V.股市,Immatics N.V.股票价格,Immatics N.V.股票交易,Immatics N.V.股票购买,Immatics N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immatics N.V.(IMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immatics N.V.(IMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}